Abstract
Over the past several years, the exponential growth in the use of topical and systemic medications and drugs has been accompanied by a concomitant increase in the incidence of adverse reactions associated with them. One type of reaction that has been of particular interest to dermatologists has been the development of immunologic photosensitivity to topically applied and orally administered substances. The majority of agents that have been identified as causing photoallergic reactions in a significant percentage of individuals are no longer utilized. However, because new products are introduced with increasing frequency, this type of photosensitivity disease promises to be an ongoing problem for the dermatologic community.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
